56 top medical experts on Navajo neurohepatopathy across 9 countries and 7 U.S. states, including 12 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Navajo neurohepatopathy: A rare, life-threatening, mitochondrial DNA depletion syndrome disease characterized by severe, progressive sensorimotor neuropathy associated with corneal ulceration, scarring or anesthesia, acral mutilation, metabolic and immunologic derangement, and hepatopathy (which can manifest with fulminant hepatic failure, a Reye-like syndrome or indolent progression to liver cirrhosis, depending on clinical form involved), present in the Navajo Native American population. Clinical presentation includes failure to thrive, distal limb weakness with reduced sensation, limb contractures with loss of function, areflexia, recurrent metabolic acidosis with intercurrent illness, immunologic anomalies manifesting with severe systemic infections, and sexual infantilism.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Support Organizations
  4. Synonyms: MPV17-Associated Hepatocerebral MDS,  MPV17-Related Hepatocerebral Mitochondrial DNA Depletion Syndrome,  MTDPS6,  Mitochondrial Dna Depletion Syndrome 6,  Navajo Familial Neurogenic Arthropathy,  Navajo neuropathy


  

        

                    


    Computing Expert Listing ...